These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Notable increased cerebrospinal fluid levels of soluble interleukin-6 receptors in neuromyelitis optica. Wang H, Wang K, Zhong X, Dai Y, Qiu W, Wu A, Hu X. Neuroimmunomodulation; 2012; 19(5):304-8. PubMed ID: 22777162 [Abstract] [Full Text] [Related]
5. Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis. Quan C, Yu H, Qiao J, Xiao B, Zhao G, Wu Z, Li Z, Lu C. Mult Scler; 2013 Mar; 19(3):289-98. PubMed ID: 22864301 [Abstract] [Full Text] [Related]
6. Increased soluble C5b-9 in CSF of neuromyelitis optica. Wang H, Wang K, Wang C, Qiu W, Lu Z, Hu X. Scand J Immunol; 2014 Feb; 79(2):127-30. PubMed ID: 24313854 [Abstract] [Full Text] [Related]
11. The HMGB1 is increased in CSF of patients with an Anti-NMDAR encephalitis. Ai P, Zhang X, Xie Z, Liu G, Liu X, Pan S, Wang H. Acta Neurol Scand; 2018 Feb; 137(2):277-282. PubMed ID: 29023630 [Abstract] [Full Text] [Related]
12. Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse. Shu Y, Li R, Yang Y, Dai Y, Qiu W, Chen Y, Zhao Z, Lu Z, Hu X. Neurochem Int; 2015 Feb; 81():28-31. PubMed ID: 25555815 [Abstract] [Full Text] [Related]
16. Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis. Uzawa A, Mori M, Uchida T, Masuda H, Ohtani R, Kuwabara S. Clin Chim Acta; 2016 Jan 30; 453():131-3. PubMed ID: 26686775 [Abstract] [Full Text] [Related]
17. Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis. Uzawa A, Mori M, Ito M, Uchida T, Hayakawa S, Masuda S, Kuwabara S. J Neurol; 2009 Dec 30; 256(12):2082-4. PubMed ID: 19655191 [Abstract] [Full Text] [Related]